SignatureFD’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,434
Closed -$738K 2374
2019
Q3
$738K Buy
7,434
+1,379
+23% +$131K 0.06% 133
2019
Q2
$560K Buy
6,055
+54
+0.9% +$5.13K 0.05% 163
2019
Q1
$566K Buy
6,001
+606
+11% +$53K 0.05% 161
2018
Q4
$346K Sell
5,395
-7,226
-57% -$533K 0.03% 226
2018
Q3
$1.13M Sell
12,621
-82,215
-87% -$7.27M 0.11% 79
2018
Q2
$7.53M Buy
94,836
+87,214
+1,144% +$7.24M 0.84% 17
2018
Q1
$680K Buy
7,622
+2,231
+41% +$214K 0.08% 99
2017
Q4
$563K Sell
5,391
-242
-4% -$27.3K 0.07% 129
2017
Q3
$821K Sell
5,633
-63
-1% -$8.58K 0.11% 75
2017
Q2
$740K Buy
5,696
+314
+6% +$38.5K 0.11% 67
2017
Q1
$670K Buy
5,382
+881
+20% +$105K 0.1% 81
2016
Q4
$521K Buy
4,501
+112
+3% +$12.5K 0.09% 91
2016
Q3
$459K Buy
4,389
+553
+14% +$59.9K 0.07% 104
2016
Q2
$378K Buy
3,836
+47
+1% +$4.86K 0.06% 103
2016
Q1
$379K Buy
3,789
+195
+5% +$20.1K 0.06% 94
2015
Q4
$430K Buy
3,594
+38
+1% +$4.4K 0.08% 69
2015
Q3
$385K Sell
3,556
-212
-6% -$26.3K 0.09% 74
2015
Q2
$436K Buy
3,768
+137
+4% +$15.7K 0.09% 72
2015
Q1
$419K Sell
3,631
-393
-10% -$47K 0.1% 75
2014
Q4
$450K Sell
4,024
-306
-7% -$32.3K 0.11% 66
2014
Q3
$410K Sell
4,330
-930
-18% -$83.9K 0.13% 60
2014
Q2
$452K Buy
5,260
+5,150
+4,682% +$392K 0.16% 56
2014
Q1
$8K Sell
110
-366
-77% -$29K ﹤0.01% 458
2013
Q4
$40K Hold
476
0.01% 251
2013
Q3
$37K Hold
476
0.02% 252
2013
Q2
$28K Buy
+476
New +$28.6K 0.01% 230

Other funds holding CELG

SignatureFD's CELG Position: Q4 2019 in Review

SignatureFD sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,434 shares — an estimated $738K sold.

SignatureFD first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.53M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SignatureFD reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SignatureFD sold 7,434 Celgene Corp shares in Q4 2019, an estimated $738K.
  • SignatureFD first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • SignatureFD's Celgene Corp position peaked at $7.53M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SignatureFD's 13F filing for Q4 2019, filed 5 Feb 2020.